SDC1 and neoplasm: Specifically, a study from Nijhof IS et al. [8] reported that CD38 expression is reduced in both BM and PB CD138+ cells, together with non-tumor immune cells (NK, T cells, B cells, and monocytes) following the first DARA infusion and it increases again following DARA discontinuation [8].